tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCYC Stock Latest News

Bicycle Therapeutics Announces Key Leadership Changes
Company AnnouncementsBicycle Therapeutics Announces Key Leadership Changes
12d ago
8K
BCYC
Bicycle names Pierre Legault chairman, Eric Westin chief medical officer
PremiumThe Fly
Bicycle names Pierre Legault chairman, Eric Westin chief medical officer
12d ago
BCYC
Promising Upside for Bicycle Therapeutics: Buy Rating Backed by Positive Clinical Data and Market Potential for ZP Treatment
PremiumRatings
Promising Upside for Bicycle Therapeutics: Buy Rating Backed by Positive Clinical Data and Market Potential for ZP Treatment
27d ago
BCYC
Bicycle Therapeutics: Promising Pipeline Progress and Expansion Opportunities Drive Buy Rating
PremiumRatings
Bicycle Therapeutics: Promising Pipeline Progress and Expansion Opportunities Drive Buy Rating
1M ago
BCYC
Bicycle Therapeutics Reports 2024 Progress and Financial Results
PremiumCompany Announcements
Bicycle Therapeutics Reports 2024 Progress and Financial Results
1M ago
BCYC
Promising Developments and Strong Financial Position Drive Positive Outlook for Bicycle Therapeutics
PremiumRatingsPromising Developments and Strong Financial Position Drive Positive Outlook for Bicycle Therapeutics
1M ago
BCYC
Bicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
Premium
Ratings
Bicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
1M ago
BCYC
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
Premium
Ratings
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
1M ago
BCYC
Bicycle Therapeutics: Promising Clinical Advances and Strong Financial Position Support Buy Rating
PremiumRatings
Bicycle Therapeutics: Promising Clinical Advances and Strong Financial Position Support Buy Rating
1M ago
BCYC
Bicycle Therapeutics price target lowered to $42 from $53 at Jefferies
PremiumThe Fly
Bicycle Therapeutics price target lowered to $42 from $53 at Jefferies
1M ago
BCYC
Bicycle Therapeutics reports Q4 EPS (75c), consensus (85c)
PremiumThe Fly
Bicycle Therapeutics reports Q4 EPS (75c), consensus (85c)
1M ago
BCYC
Bicycle Therapeutics Reports Promising Trial Results and Future Plans
PremiumCompany Announcements
Bicycle Therapeutics Reports Promising Trial Results and Future Plans
3M ago
8K
BCYC
Bicycle announces topline data for zelenectide pevedotin plus pembrolizumab
PremiumThe FlyBicycle announces topline data for zelenectide pevedotin plus pembrolizumab
3M ago
BCYC
Bicycle Therapeutics price target lowered to $26 from $32 at JMP Securities
Premium
The Fly
Bicycle Therapeutics price target lowered to $26 from $32 at JMP Securities
4M ago
BCYC
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
VIR
BCYC
Bicycle Therapeutics price target lowered to $33 from $55 at H.C. Wainwright
PremiumThe Fly
Bicycle Therapeutics price target lowered to $33 from $55 at H.C. Wainwright
4M ago
BCYC
Bicycle Therapeutics price target lowered to $17 from $28 at B. Riley
PremiumThe Fly
Bicycle Therapeutics price target lowered to $17 from $28 at B. Riley
4M ago
BCYC
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
4M ago
LLY
ARVN
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
4M ago
BCYC
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyMolson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
5M ago
HD
SG
Bicycle Therapeutics initiated with an Equal Weight at Stephens
Premium
The Fly
Bicycle Therapeutics initiated with an Equal Weight at Stephens
5M ago
BCYC
Stephens sees ‘uphill battle’ for Bicycle Therapeutics, starts at Equal Weight
Premium
The Fly
Stephens sees ‘uphill battle’ for Bicycle Therapeutics, starts at Equal Weight
5M ago
BCYC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >